Joe Biden Raises Prostate Cancer Awareness, Urges Men to Discuss Screening With Their Doctors
HHS Announces Four Key FDA Leadership Selections Across CDER, CBER, CTP and AI
Cureety Acquires Reimagine Care, Assembling a Transatlantic Platform for Cancer Care Between Visits
Adam B. Weiner: Exercise Improved QoL For Patients on ADT For Prostate Cancer
Liliana Vasquez: Pleased to Share Ecuador’s Experience Advancing Childhood Cancer Care
Targeted Therapy in Advanced NSCLC: From Driver Matching to Adaptive Precision Oncology
Nicholas DeVito։ Why an mRNA Vaccine Worked in Melanoma and Not CRC
Eric Singhi: 10 WCLC26 Abstracts Beyond the Presidentials to Watch
The U.S. Food and Drug Administration (FDA) will convene the Molecular and Clinical Genetics Panel of the Medical Devices Advisory Committee on September 23, 2026, from 9:00 AM to 6:00 PM ET, in Silver Spring, Maryland, with virtual access also available. During the open session, the committee will discuss, make recommendations, and vote on GRAIL’s […]
The Advancing Bioequivalence Frameworks for Inhalation Drug Products: Optimizing In Vitro, In Vivo, and In Silico Methods workshop, co-hosted by the U.S. Food and Drug Administration (FDA) and the Center […]
